Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Hypomorphic EIF2B alleles can lead to Vanishing White Matter Disease (VWMD), a leukodystrophy that causes progressive white matter loss.
|
30115954 |
2018 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our observation confirms that ovarian failure in the context of a leukodystrophy warrants mutational analysis of the genes encoding the subunits of EIF2B.
|
18678442 |
2008 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We performed a transcriptomic analysis using fibroblasts of 10 eIF2B-mutated patients with a severe phenotype and 10 age matched patients with other types of LD in comparison to control fibroblasts.
|
22737209 |
2012 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in eukaryotic initiation factor 2B (eIF2B) cause one of the most common leukodystrophies, childhood ataxia with CNS hypomyelination/vanishing white matter disease or CACH/VWM.
|
16378743 |
2006 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Ninety-three individuals (78 families) with an undetermined leukodystrophy were selected on MRI-based criteria of childhood ataxia with central hypomyelination/vanishing white matter (CACH/VWM) for EIF2B genes analysis.
|
15136673 |
2004 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM) is a heritable leukodystrophy linked to mutations in translation initiation factor 2B (eIF2B).
|
15723074 |
2005 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) is a fatal leukodystrophy that is caused by mutations in genes encoding subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
26974157 |
2016 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) disease is an autosomal genetic leukodystrophy caused by mutations in subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
30279648 |
2018 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the eukaryotic translation initiation factor 2B (eIF2B) represent a heterogenous group of autosomal recessive leucodystrophy characterized by a diffuse CSF-like aspect of the white matter at MRI designed as vanishing white matter (VWM) and episodes of acute deterioration after stresses.
|
18005052 |
2008 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This is a study estimating diagnostic accuracy of CSF asialotransferrin to transferrin ratio measurement in eIF2B related disorders by using clinical evaluation and EIF2B mutation analysis as the reference standard. eIF2B-related disorder is a relatively common leukodystrophy with broad phenotypic variation that is caused by mutations in any of the five EIF2B genes.
|
18519871 |
2008 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukodystrophy with vanishing white matter (VWM) is a neurodegenerative disorder with autosomal recessive traits that is caused by alteration of the eukaryotic translation initiation factor-2B (EIF2B).
|
22678813 |
2012 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF) and a key regulator of translation initiation under normal and stress conditions, causes an autosomal recessive leukodystrophy of a wide clinical spectrum.
|
20958979 |
2010 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in eIF2B genes cause vanishing white matter disease (VWMD), a fatal leukodystrophy that can manifest following physical trauma or illness, conditions that activate the integrated stress response (ISR).
|
29632131 |
2018 |
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) disease (OMIM#306896) is an autosomal recessive neurodegenerative leukodystrophy caused by hypomorphic mutations in any of the five genes encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
31134486 |
2019 |
Protein C measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
Protein C antigen measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci.
|
30108127 |
2018 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we have established cell cultures from the brain of an individual with VWM carrying mutations in subunit 5 of eIF2B (encoded by EIF2B5).
|
15723074 |
2005 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It is already known that alterations in Eukaryotic Translation Initiation Factor 2B (EIF2B) gene encoding the five subunits of eIF2B complex cause Vanishing White Matter (VWM) disease of the brain and emerging evidences have advocated certain resemblances between MS and VWM in terms of clinical and epidemiological characteristics, thus validating the association study between EIF2B and MS.
|
26671108 |
2015 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report in an affected man and his mother an adult-onset form of childhood ataxia with central nervous system hypomyelination/vanishing white matter disease-like disorder with no mutations in the EIF2B genes and normal guanine nucleotide exchange factor eIF2B activity, suggesting a new dominant inheritance of this syndrome that may involve other genes.
|
16047349 |
2005 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) disease (OMIM#306896) is an autosomal recessive neurodegenerative leukodystrophy caused by hypomorphic mutations in any of the five genes encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
31134486 |
2019 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM; MIM #603896), also known as childhood ataxia with central nervous system hypomyelination (CACH) syndrome, is an autosomal recessive transmitted leukoencephalopathy related to mutations in each of the 5 genes (EIF2B1, EIF2B2, EIF2B3, EIF2B4 and EIF2B5) encoding for the 5 subunits of eukaryotic translation initiation factor 2B (eIF2B), essential for protein synthesis.
|
16998732 |
2006 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM) is an autosomal recessive neurological disorder caused by mutation(s) in any subunit of eukaryotic translation initiation factor 2B (eIF2B), an activator of translation initiation factor eIF2.
|
31587290 |
2019 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in eIF2B have also recently been found to cause a fatal human disease called CACH (childhood ataxia with central nervous system hypomyelination) or VWM (vanishing white matter disease).
|
16246152 |
2005 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A unique EIF2B mutation spectrum in Chinese VWM patients was shown.
|
19158808 |
2009 |